The flow cytometric results determined that either IL-4-, IL13-, or IL-17-producing CD4 T cells were increased by AD induction, and that these populations were smaller in the spleens and lymph nodes from AES16-2M treated mice (Figure 2). This evidence concerns the gene CD4 and Alzheimer disease.